Cyclacel Pharmaceuticals News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

18.03.24	Earnings Outlook For Cyclacel Pharmaceuticals (Benzinga)
22.12.23	Why Cyclacel Pharmaceuticals (CYCC) Shares Are Getting Obliterated (Benzinga)
23.12.20	CYCC Gets $7Mln Strategic Investment, SUPN Abuzz, SNGX Plunges On Oral Mucositis Trial Data (RTTNews)
21.04.20	CYCC In STOPCOVID, EXEL Hits New High, NVS Trialing Malaria Drug For COVID-19 (RTTNews)
20.04.20	Stock Alert: Cyclacel Pharma Shares Up 53% In Premarket (RTTNews)
05.04.17	Gainers & Losers Of Apr.4: INNL, BNTC, PRTK, CRVS, STDY... (RTTNews)
04.04.17	Gainers & Losers Of The Day: CYCC, NVCR, STDY, ACOR, OREX... (RTTNews)
09.03.17	Gainers & Losers Of Mar.8: GBT, CYCC, GNMX, MGCD, TRVN... (RTTNews)
28.02.17	Gainers & Losers Of Feb.27: LJPC, NVAX, KTOV, CYCC, ARGS... (RTTNews)
15.11.16	FDA Snubs DVAX, Keep An Eye On OCUL, It's All Green For BLUE (RTTNews)
08.02.16	Trouble For CTIC, It's A Thumbs Up For BMY, CYCC On Notice Again, VRTX Snubbed (RTTNews)
17.12.14	ASPX Flies On Trial Data, CYCC Knocked Down, NVGN Creates Buzz, BVX On Watch (RTTNews)
16.12.14	Cyclacel Reports Disappointing Outcome From Interim Analysis Of SEAMLESS Study (RTTNews)
09.10.14	Cyclacel Pharma Says DSMB Recommends To Continue SEAMLESS Phase 3 Study In AML (RTTNews)
18.09.14	Cyclacel's CYC065 CDK Inhibitor Shows Therapeutic Potential In Acute Leukemias (RTTNews)
04.04.14	Cyclacel Pharma Prices Public Offering Of 2.86 Mln Shares At $3.50 Per Share (RTTNews)
09.12.13	Cyclacel Pharma Reports Data From Phase 2 Sapacitabine Trial - Quick Facts (RTTNews)
26.11.13	Echo Sounds Louder, PBMD Gets Prime Attention, Xmas Coming Early For CYCC (RTTNews)
25.11.13	Cyclacel: Independent Monitoring Board Supports Sapacitabine Phase 3 Study (RTTNews)
05.11.13	Cyclacel Pharma Gets Two Patents Extending Exclusivity Of Sapacitabine (RTTNews)
20.09.13	Pre-market Movers For Sept 20 (AAPL, GT, VRNM, CYCC, TIBX, RNA, SRPT, DRI) (RTTNews)
20.09.13	Did You Buy These Stocks? (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V